Microbot Medical Inc. has issued a total of 2,395,715 shares of its common stock at a par value of $0.01 per share. These shares were issued upon the exercise of outstanding Series G preferred investment options by their holders at an exercise price of $1.75 per share. The transaction generated gross proceeds of approximately $4.2 million before deducting placement agent fees and expenses. These shares were issued under the exemption provided by Section 4(a)(2) of the Securities Act of 1933 and were registered for resale on a Registration Statement on Form S-3.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.